Expert Ratings for MorphoSys
Portfolio Pulse from Benzinga Insights
MorphoSys (NASDAQ:MOR) has received 4 analyst ratings in the last quarter, with 2 being somewhat bullish and 2 indifferent. There have been no bullish or bearish ratings. The average price target for MorphoSys is now $10.05, which is significantly higher than its current price of $4.28, suggesting a substantial upside. This average price target has increased by 83.39% from the previous target of $5.48. Analyst ratings are opinions on stock performance and are updated quarterly.
November 22, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
MorphoSys has an updated average analyst price target of $10.05, an 83.39% increase from the previous target, with current ratings suggesting a positive outlook.
The substantial increase in the average price target for MorphoSys suggests that analysts have a positive outlook on the stock, which could lead to increased investor interest and a potential rise in the stock price in the short term. The confidence score is high due to the clear consensus among analysts and the significant increase in the price target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100